...
首页> 外文期刊>ACS Sustainable Chemistry & Engineering >Use of Ionic Liquids as Cosurfactants in Mixed Aqueous Micellar Two-Phase Systems to Improve the Simultaneous Separation of Immunoglobulin G and Human Serum Albumin from Expired Human Plasma
【24h】

Use of Ionic Liquids as Cosurfactants in Mixed Aqueous Micellar Two-Phase Systems to Improve the Simultaneous Separation of Immunoglobulin G and Human Serum Albumin from Expired Human Plasma

机译:将离子液体用作混合胶束胶束两相体系中的含有含有含量的,以改善免疫球蛋白G和Humlum血清白蛋白从过期的人血浆的同时分离

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A large fraction of unused clinical transfusion plasma is nowadays discarded. Nevertheless, some proteins, including serum albumin, immunoglobulins, and clot factors, are still viable for use in diagnosis or research. However, lasma is a complex matrix, requiring multiple steps and time-consuming methods for the isolation of proteins. In this work, aqueous micellar two-phase systems (AMTPS) composed of nonionic surfactants (Triton X-114 or Tergitol 15-S-7) were investigated to simultaneously separate immunoglobulin G (IgG) and human serum albumin (HSA) from human expired plasma. A factorial planning was applied to the nonionic surfactant and plasma concentrations to enhance the systems separation performance. After identifying the best conditions with AMTPS formed by nonionic surfactants, mixed AMTPS formed by Tergitol 15-S-7 and various surface-active ionic liquids (SAILs) acting as cosurfactants were additionally investigated to tailor the proteins partition between the two phases. The mixed AMTPS composed of Tergitol 15-S-7 as the nonionic surfactant and tributyltetradecylphosphonium chloride as the cosurfactant at pH 8.0 improved the simultaneous separation of both proteins to the opposite phases. IgG purification of 1.14-fold in the surfactant-poor phase and HSA purification of 1.36-fold in the surfactant-rich phase were obtained. Method reproducibility was investigated using additional samples of human serum and plasma and serum mixtures. Although improvements in the purification factor of each protein are still a future goal, mixed AMTPS comprising nonionic surfactants and SAILs as cosurfactants may be considered as novel platforms to be used in the simultaneous separation of value-added compounds from complex and natural matrices.
机译:如今丢弃了大部分未使用的临床输血等离子体。然而,一些蛋白质,包括血清白蛋白,免疫球蛋白和凝块因子,仍然可用于诊断或研究。然而,达拉是一种复杂的基质,需要多个步骤和耗时的蛋白质分离的方法。在这项工作中,研究了由非离子表面活性剂(Triton X-114或Tergitol 15-S-7)组成的水性胶束式两相系统(AMTP),同时将来自人过期的免疫球蛋白G(IgG)和人血清白蛋白(HSA)分离等离子体。将阶乘规划应用于非离子表面活性剂和血浆浓度,以增强系统分离性能。在用非离子表面活性剂形成的AMTPS鉴定最佳条件后,另外研究了由Tergitol 15-S-7形成的混合式AMTP和作用作含有含有含有含有含有含有植物质料的载体。作为非离子表面活性剂和ThegutyltexteCyl氯化物,作为苯酰氯,在pH8.0下的含有苯二甲酰基氯化物组成的混合式AMTP改善了两种蛋白质与相对相的同时分离。获得在表面活性剂相差的IgG纯化1.14倍,得到富含表面活性剂的相中的1.36倍的HSA纯化。使用额外的人血清和血浆和血清混合物研究了方法再现性。尽管每个蛋白质的纯化因子的改进仍然是未来的目标,但是包含非离子表面活性剂和帆船的混合AMTP可以被认为是用于同时分离复合物和天然基质的增值化合物的新颖平台。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号